Jade Biosciences, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Jade Biosciences, Inc.'s yearly results, compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
Cash quality
Profit Cash Ratio
—Data incomplete
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
—Data incomplete
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
—Data incomplete
Cash Cushion Ratio
+35%Cash, after subtracting all debt, equals 35% of its market value (net cash).
Higher than 71% of Healthcare companies in United States.
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (8)
Jade Biosciences, Inc. made a loss over the last year. Jade Biosciences, Inc. owes $0.07 for every $1 it owns.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossJade Biosciences, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
2.16The share price is 2.16 times Jade Biosciences, Inc.'s book value per share, lower than 55% of Healthcare companies in United States.
Market cap
$948 MThe total market value of all of Jade Biosciences, Inc.'s shares at today's price (share price × number of shares), larger than 63% of Healthcare companies in United States. PosiCap size class: Mini Cap.
Net worth (book value)
$440 MWhat Jade Biosciences, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$6.92Net worth divided by the number of shares. The share price of $14.91 is 2.2 times this, which is the P/B above.
Owes vs Owns
0.07×Jade Biosciences, Inc. owes $0.07 for every $1 it owns (low), lower than 92% of Healthcare companies in United States.
Dividend yield
NoneJade Biosciences, Inc. does not currently pay a dividend.
Cash vs debt
Net cashJade Biosciences, Inc. held $335 M more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Jade Biosciences, Inc.: $948 M ÷ $440 M (30 Jun 2026) = 2.2.
How much does Jade Biosciences, Inc. owe compared with what it owns?
Jade Biosciences, Inc. owes $0.07 for every $1 it owns (low), lower than 92% of Healthcare companies in United States.
Does Jade Biosciences, Inc. pay a dividend?
No. Jade Biosciences, Inc. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.